We are live on ! Find out more
PCA

Private Capital Advisors Portfolio holdings

AUM $1.14B
1-Year Est. Return 48.66%
This Fund
S&P 500
This Quarter Est. Return
-0.76%
1 Year Est. Return
+48.66%
3 Year Est. Return
+137.63%
5 Year Est. Return
+227.94%
10 Year Est. Return
+772.14%
AUM
$307M
AUM Growth
+$31.9M
Cap. Flow
+$40.1M
Cap. Flow %
13.06%
Top 10 Hldgs %
24.74%
Holding
140
New
26
Increased
30
Reduced
34
Closed
7

Top Buys

Rank Stock Value
1
TRIL
Trillium Therapeutics Inc.
TRIL
+$9.59M
2
TMO icon
Thermo Fisher Scientific
TMO
+$6.03M
3
GE icon
GE Aerospace
GE
+$5.63M
4
META icon
Meta Platforms (Facebook)
META
+$4.15M
5
CMCSA icon
Comcast
CMCSA
+$2.75M

Top Sells

Rank Stock Value
1
IONS icon
Ionis Pharmaceuticals
IONS
+$4.53M
2
MGNX icon
MacroGenics
MGNX
+$1.86M
3
TWTR
Twitter, Inc.
TWTR
+$1.43M
4
ICPT
Intercept Pharmaceuticals, Inc.
ICPT
+$1.26M
5
EOG icon
EOG Resources
EOG
+$1.15M

Sector Composition

Rank Sector Weight
1 Healthcare 27.28%
2 Communication Services 20.72%
3 Energy 14.2%
4 Industrials 11.62%
5 Technology 9.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PH icon
101
Parker-Hannifin
PH
$125B
$434K 0.14%
3,727
– –
LBRDA
102
DELISTED
Liberty Broadband Class A
LBRDA
$421K 0.14%
8,259
+864
+12% +$46K
ENDP
103
DELISTED
Endo International plc
ENDP
$418K 0.14%
+5,250
New +$453K
SPY icon
104
State Street SPDR S&P 500 ETF Trust
SPY
$825B
$396K 0.13%
+1,925
New +$405K
MDSO
105
DELISTED
Medidata Solutions, Inc.
MDSO
$386K 0.13%
7,100
+400
+6% +$21.5K
NFLX icon
106
Netflix
NFLX
$340B
$361K 0.12%
38,500
+3,500
+10% +$29.3K
SIOX
107
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
$346K 0.11%
+2,125
New +$360K
LLL
108
DELISTED
L3 Technologies, Inc.
LLL
$340K 0.11%
3,000
– –
PBYI icon
109
Puma Biotechnology
PBYI
$468M
$336K 0.11%
+2,875
New +$521K
IBM icon
110
IBM
IBM
$222B
$333K 0.11%
2,144
– –
PG icon
111
Procter & Gamble
PG
$334B
$313K 0.1%
4,000
– –
WMT icon
112
Walmart Inc
WMT
$820B
$309K 0.1%
13,065
– –
GS icon
113
Goldman Sachs
GS
$301B
$298K 0.1%
1,425
– –
XLV icon
114
State Street Health Care Select Sector SPDR ETF
XLV
$44.5B
$298K 0.1%
4,000
– –
TVRD
115
Tvardi Therapeutics
TVRD
$24.3M
$287K 0.09%
+656
New +$254K
ED icon
116
Consolidated Edison
ED
$39.8B
$252K 0.08%
4,350
– –
HES
117
DELISTED
Hess
HES
$241K 0.08%
3,600
– –
BRK.B icon
118
Berkshire Hathaway Class B
BRK.B
$1.08T
$211K 0.07%
1,550
– –
BTX.WS
119
DELISTED
BioTime Inc Warrants (Expiring October 1, 2018)
BTX.WS
$83K 0.03%
72,341
– –
PM icon
120
Philip Morris
PM
$299B
– –
-14,090
Closed -$1.06M
SIRI icon
121
SiriusXM
SIRI
$9.62B
– –
-21,197
Closed -$810K
TWTR
122
DELISTED
Twitter, Inc.
TWTR
– –
-28,508
Closed -$1.43M
MON
123
DELISTED
Monsanto Co
MON
– –
-3,755
Closed -$423K
DD
124
DELISTED
Du Pont De Nemours E I
DD
– –
-3,054
Closed -$207K
1 2 3 4
5

Similar funds

SC
Shellback Capital Boston, Massachusetts $1.14B AUM 49.89% 1-Year Est. Return
MIG
McGuire Investment Group Wakefield, Rhode Island $1.14B AUM 79.59% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $1.14B AUM 6.91% 1-Year Est. Return
RIM
RW Investment Management Eagle, Idaho $1.14B AUM
VCP
Vista Capital Partners Portland, Oregon $1.14B AUM 21.34% 1-Year Est. Return
HGIM
High Ground Investment Management London, United Kingdom $1.14B AUM 29.32% 1-Year Est. Return
CAM
Carret Asset Management New York $1.14B AUM 35.33% 1-Year Est. Return
SIM
Symetra Investment Management Farmington, Connecticut $1.14B AUM 10.76% 1-Year Est. Return

Private Capital Advisors's Q2 2015 Portfolio in Review

As of Q2 2015, Private Capital Advisors held 140 positions worth $307M, up 12% from $275M the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Private Capital Advisors deployed $40.1M of net new capital in Q2 2015, opening 26 new positions and adding to 30 existing holdings. Its largest new stake was Thermo Fisher Scientific: 46,230 shares worth $6M.

By sector, the portfolio is most concentrated in Healthcare at 27% of assets, up from 25% a quarter earlier, followed by Communication Services and Energy.

On the sell side, the largest reduction was Ionis Pharmaceuticals, an estimated $4.53M trimmed.

  • Private Capital Advisors's largest Q2 2015 buy was Thermo Fisher Scientific: 46,230 shares worth $6M.
  • Private Capital Advisors added most to Trillium Therapeutics Inc. in Q2 2015, an estimated $9.59M increase.
  • Private Capital Advisors's biggest Q2 2015 reduction was Ionis Pharmaceuticals, cutting an estimated $4.53M.
  • Private Capital Advisors fully exited Twitter, Inc. in Q2 2015, selling an estimated $1.43M.
  • Private Capital Advisors's ten largest holdings make up 25% of its $307M portfolio in Q2 2015.
  • Private Capital Advisors opened 26 new positions and closed 7 in Q2 2015.
  • Private Capital Advisors's portfolio value rose 12% quarter-over-quarter to $307M.

Based on Private Capital Advisors's 13F filing for Q2 2015, filed 6 Aug 2015.